Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
United States Gasoline Fund Lp
UGA
US Stock MarketDetailed Quotes
ASTELLAS PHARMA (ALPMF)
- 15.450
- -0.200-1.28%
15min DelayClose Sep 10 09:30 ET
27.68BMarket Cap14.70P/E (TTM)
15.450High15.450Low168Volume15.450Open15.650Prev Close2.60KTurnover0.00%Turnover Ratio14.70P/E (Static)1.79BShares17.85052wk High2.37P/B27.68BFloat Cap9.70052wk Low0.49Dividend TTM1.79BShs Float17.850Highest3.18%Div Yield TTM0.00%Range %8.084Lowest15.450Avg Price1Lot Size
ASTELLAS PHARMA (ALPMF) News
Citi Maintains ASTELLAS PHARMA(ALPMF.US) With Hold Rating, Raises Target Price to $15.65
Citi analyst Hidemaru Yamaguchi maintains $ASTELLAS PHARMA(ALPMF.US)$ with a hold rating, and adjusts the target price from $14.95 to $15.65.According to TipRanks data, the analyst has a success
Astellas Pharma ADR GAAP EPS of ¥78.96, Revenue of ¥640.91B; Reaffirms FY 2027 Outlook
Pfizer, Astellas Expand PADCEV-Keytruda Label With FDA Nod In Bladder Cancer
On Friday, the U.S. Food and Drug Administration (FDA) approved Pfizer Inc.'s (NYSE:PFE) and Astellas Pharma Inc.'s (OTC:ALPMF) (OTC:ALPMY) PADCEV (enfortumab vedotin-ejfv) combo regimen for bladder
Merck Gains EU Approval of Keyruda, Padcev Combo for Bladder Cancer
Sangamo Bankruptcy Puts Gene Therapy Platforms In Play, Eli Lilly And Astellas Circle
Sangamo Therapeutics Inc. (NASDAQ:SGMO) filed for Chapter 11 bankruptcy protection on Tuesday, as the gene therapy company seeks to sell its assets through a court-supervised process.The gene-
Ironwood, AbbVie Win U.S. Label Expansion for Linzess in Pediatric Constipation
AbbVie, Merck, Astra Among Winners of EU Drug Recommendations This Week
Citi Maintains ASTELLAS PHARMA(ALPMF.US) With Hold Rating, Cuts Target Price to $15.28
Citi analyst Hidemaru Yamaguchi maintains $ASTELLAS PHARMA(ALPMF.US)$ with a hold rating, and adjusts the target price from $15.91 to $15.28.According to TipRanks data, the analyst has a success
Pfizer, Astellas Win FDA Priority Review for Padcev in Bladder Cancer With Merck's Keytruda
ORIC Pharma Drops After Early-stage Trial Data for Prostate Cancer Therapy
ASTELLAS PHARMA To Go Ex-Dividend On March 30th, 2026 With 0.3432 USD Dividend Per Share
March 26th (Eastern Time) - $ASTELLAS PHARMA(ALPMF.US)$ is trading ex-dividend on March 30th, 2026.Shareholders of record on March 31st, 2026 will receive 0.3432 USD dividend per share on June 3rd, 20
Jefferies Upgrades ASTELLAS PHARMA(ALPMF.US) to Buy Rating, Raises Target Price to $17.56
Jefferies analyst Stephen Barker upgrades $ASTELLAS PHARMA(ALPMF.US)$ to a buy rating, and adjusts the target price from $10.23 to $17.56.According to TipRanks data, the analyst has a success rate
Pfizer Posts Late-stage Trial Win for Talzenna Plus Xtandi in New Prostate Cancer Indication
No More
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On September 1, U.S. Eastern Time, the U.S. military launched a new round of strikes against Iran in response to recent attempts by the Isla
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm